Krebs Von den Lungen-6 as a predictive indicator for the risk of secondary pulmonary fibrosis and its reversibility in COVID-19 patients

被引：0
|
作者：
Xue, Mingshan [1 ]
Zhang, Teng [2 ]
Chen, Hao [3 ]
Zeng, Yifeng [3 ]
Lin, Runpei [3 ]
Li, Ning [3 ]
Huang, Zhifeng [3 ]
Zhou, Luqian [3 ]
Zhang, Xiaohua Douglas [2 ]
Sun, Baoqing [3 ]
机构：
[1] Guangzhou Lab, Guangzhou, Peoples R China
[2] Univ Macau, Fac Hlth Sci, Guangzhou, Peoples R China
[3] Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
来源：
EUROPEAN RESPIRATORY JOURNAL | 2023年 / 62卷
关键词：
D O I：
10.1183/13993003.congress-2023.PA3836
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Changes in blood Krebs von den Lungen-6 predict the mortality of patients with acute exacerbation of interstitial lung disease
    Choi, Myeong Geun
    Choi, Sun Mi
    Lee, Jae Ha
    Yoon, Jung-Ki
    Song, Jin Woo
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [42] Changes in blood Krebs von den Lungen-6 predict the mortality of patients with acute exacerbation of interstitial lung disease
    Myeong Geun Choi
    Sun Mi Choi
    Jae Ha Lee
    Jung-Ki Yoon
    Jin Woo Song
    Scientific Reports, 12
  • [43] Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer
    Tanaka, Sonosuke
    Hattori, Noboru
    Ishikawa, Nobuhisa
    Shoda, Hiroyasu
    Takano, Atsushi
    Nishino, Ryohei
    Okada, Morihito
    Arihiro, Koji
    Inai, Kouki
    Hamada, Hironobu
    Yokoyama, Akihito
    Kohno, Nobuoki
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (02) : 377 - 387
  • [44] Serum Krebs von den Lungen-6 (KL-6) level as a prognostic biomarker in patients with interstitial lung abnormalities (ILA)
    Park, Hye Kyeong
    Yoon, Young-Soon
    Song, Jae-Uk
    Kang, Hyung Koo
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [45] Prognostic value of initial KL-6 (Krebs von den Lungen 6) plasma level during COVID-19 pneumonia
    Letellier, A.
    Rolland-Debord, C.
    Paz, D. Luque
    Lefevre, G.
    Pieroni, L.
    Parrot, A.
    Cadranel, J.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [46] Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II
    d'Alessandro, Miriana
    Bergantini, Laura
    Cavallaro, Dalila
    Gangi, Sara
    Cameli, Paolo
    Conticini, Edoardo
    Frediani, Bruno
    Dotta, Francesco
    Bargagli, Elena
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 (04)
  • [47] Elevated Serum Krebs von den Lungen-6 in Early Disease Predicts Subsequent Deterioration of Pulmonary Function in Patients with Systemic Sclerosis and Interstitial Lung Disease
    Kuwana, Masataka
    Shirai, Yuichiro
    Takeuchi, Tsutomu
    JOURNAL OF RHEUMATOLOGY, 2016, 43 (10) : 1825 - 1831
  • [48] High Risk of Krebs Von Den Lungen-6 (kL-6) Elevation when Dipeptidyl Peptidase-4 Inhibitors and Amiodarone Are Prescribed Simultaneously
    Okada, Junichi
    Okada, Shuichi
    Yamada, Masanobu
    DIABETES, 2019, 68
  • [49] Clinical Relevance of the Serial Measurement of Krebs von den Lungen-6 Levels in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
    Shirai, Yuichiro
    Fukue, Ryosuke
    Kaneko, Yuko
    Kuwana, Masataka
    DIAGNOSTICS, 2021, 11 (11)
  • [50] Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease
    Qin, H.
    Xu, X. P.
    Zou, J.
    Zhao, X. J.
    Wu, H. W.
    Zha, Q. F.
    Chen, S.
    Kang, Y.
    Jiang, H. D.
    PULMONOLOGY, 2019, 25 (03): : 143 - 148
12345